GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharming Group (OTCPK:PHGUF) » Definitions » ROA %

Pharming Group (Pharming Group) ROA %

: -2.78% (As of Dec. 2023)
View and export this data going back to . Start your Free Trial

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Pharming Group's annualized Net Income for the quarter that ended in Dec. 2023 was $-12.5 Mil. Pharming Group's average Total Assets over the quarter that ended in Dec. 2023 was $449.7 Mil. Therefore, Pharming Group's annualized ROA % for the quarter that ended in Dec. 2023 was -2.78%.

The historical rank and industry rank for Pharming Group's ROA % or its related term are showing as below:

PHGUF' s ROA % Range Over the Past 10 Years
Min: -52.43   Med: 0.55   Max: 16.37
Current: -2.42

During the past 13 years, Pharming Group's highest ROA % was 16.37%. The lowest was -52.43%. And the median was 0.55%.

PHGUF's ROA % is ranked better than
80.94% of 1558 companies
in the Biotechnology industry
Industry Median: -35.725 vs PHGUF: -2.42

Pharming Group ROA % Historical Data

The historical data trend for Pharming Group's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharming Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.18 11.19 3.92 3.32 -2.37

Pharming Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.48 -11.51 1.24 3.20 -2.78

Competitive Comparison

For the Biotechnology subindustry, Pharming Group's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharming Group ROA % Distribution

For the Biotechnology industry and Healthcare sector, Pharming Group's ROA % distribution charts can be found below:

* The bar in red indicates where Pharming Group's ROA % falls into.



Pharming Group ROA % Calculation

Pharming Group's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-10.548/( (425.797+462.854)/ 2 )
=-10.548/444.3255
=-2.37 %

Pharming Group's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-12.492/( (436.467+462.854)/ 2 )
=-12.492/449.6605
=-2.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Pharming Group  (OTCPK:PHGUF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-12.492/449.6605
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-12.492 / 324.868)*(324.868 / 449.6605)
=Net Margin %*Asset Turnover
=-3.85 %*0.7225
=-2.78 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Pharming Group ROA % Related Terms

Thank you for viewing the detailed overview of Pharming Group's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharming Group (Pharming Group) Business Description

Address
Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is engaged in the development of products for the treatment of unmet medical needs. The company focuses on developing and producing human therapeutic proteins to provide life-changing solutions to patients. Its product includes Ruconest. The revenue is generated from the United States.

Pharming Group (Pharming Group) Headlines